China News
-
China Nepstar disposes 40% equity ownership in Yunnan Jianzhijia
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: China Nepstar Chain Drugstore has completed the sales of its 40 percent equity ownership in Yunnan Jianzhijia...Read more
-
China vigilant on drug price policy
China | Regulatory | By BioSpectrum Bureau | 0 Comment | 06 Aug, 2013
Singapore: A team of China's National Health and Family Planning Commission (NHFPC) led by Mr Li Xi, head, Permanent Dis...Read more
-
Parexel opens its 6th office in China
China | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2013
Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client deman...Read more
-
ShangPharma celebrates 10 years with Eli Lilly
China | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2012
Singapore: ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, cel...Read more
-
Top 20 APAC Country Analysis: Korea
China | Analysis | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2015
Singapore: South Korea is the fourth largest contributor to the lifescience market in the region. • Korean Minis...Read more
-
A time to rethink talent management
China | Opinion | By BioSpectrum Bureau | 0 Comment | 29 May, 2012
Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It te...Read more
-
John Crowley is Charles River's CAO
China | Influencers | By BioSpectrum Bureau | 2 Comment | 27 Sep, 2013
Singapore: Charles River Laboratories has appointed Mr John Crowley to the role of corporate senior VP, corporate contro...Read more
-
Zhejiang Medicine, Ambrx to develop antibody drug conjugate for breast cancer
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaborati...Read more
-
Innovative way to meet the global HSA requirement
China | News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2012
Human serum albumin (HSA), a blood protein that is widely used in drug and vaccine production, is in high demand around ...Read more
-
BGI-Shenzhen extends tender offer for Complete Genomics
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: BGI-Shenzhen (BGI) announced that it, through its wholly owned subsidiary Beta Acquisition, has extended its...Read more
-
China Botanic gets warning from NYSE
China | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2013
Singapore: China Botanic Pharmaceutical (formerly Renhuang Pharmaceuticals) received a warning letter from the NYSE MKT...Read more
-
New strategies drive growth in Yunnan Baiyao
China | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Yunnan Baiyao made new strategies for 2011 and the year recorded relocation, expansion of the company's business develop...Read more
-
Biostar signs another $3 mn military contract within a month
China | News | By BioSpectrum Bureau | 0 Comment | 18 Oct, 2012
Singapore: China-based Biostar Pharmaceuticals signed a one-year agreement, valued at approximately $3.0 million, to man...Read more
-
Chinese to get first-ever oral rotavirus vaccine
China | News | By BioSpectrum Bureau | 0 Comment | 03 Jul, 2013
Singapore: The not-for-profit organization, International Medica Foundation, that works towards the development of a saf...Read more
-
Xiangxue Pharma acquires rights for Kinex KX02
China | News | By BioSpectrum Bureau | 0 Comment | 22 May, 2012
Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceut...Read more
-
Chinese, Hong Kong scientists map H7N9 risk infection
China | News | By BioSpectrum Bureau | 0 Comment | 08 May, 2013
Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production ...Read more
-
Mr George Baeder, Quintiles: Companies will fail to leverage on what China has to offer in 2013
China | Opinion | By BioSpectrum Bureau | 3 Comment | 25 Dec, 2012
China's role in the global drug industry will fundamentally change; most companies will fail to capitalize on this oppor...Read more
-
Takeda's diabetes drug gets Chinese FDA nod
China | Regulatory | By BioSpectrum Bureau | 1 Comment | 01 Aug, 2013
Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has ...Read more
